# Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

> **NCT05354557** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Iberdomide

## Key facts

- **NCT ID:** NCT05354557
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-26
- **Primary completion:** 2027-04-26
- **Final completion:** 2027-04-26
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354557, "Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT05354557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*